| JTS1900007 | 雷莫芦单抗 | ramucirumab | Injection | Biological Products | Disposable Import Drug Application | 2019-03-28 | Eli Lilly and Company（礼来公司） | Eli Lilly & Company | Certificate Issued | 2019-04-22 | view |
| JTS1900045 | 雷莫芦单抗 | ramucirumab | Injection | Biological Products | Disposable Import Drug Application | 2019-09-05 | Eli Lilly and Company（礼来公司） | Eli Lilly & Company | Certificate Issued | 2019-09-23 | view |
| JTS2000051 | Ramucirumab | ramucirumab | Injection | Biological Products | Disposable Import Drug Application | 2020-11-06 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2020-11-30 | view |
| JXSL1300070 | Ramucirumab | ramucirumab | Injection | Biological Products | Import Drug Application | 2013-11-08 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2015-01-08 | view |
| JXHL1900365 | Tirzepatide注射液 | tirzepatide | Injection | Chemical Drugs(1) | Import Drug Application | 2019-12-28 | Eli Lilly and Company | Eli Lilly & Company | In Review | 2019-12-27 | view |
| JYHB1000656 | 盐酸度洛西汀肠溶胶囊 | duloxetine hydrochloride | Capsule | Chemical Drugs | Supplementary Application | 2010-08-04 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2013-01-18 | view |
| JXHL1900067 | Tirzepatide注射液 | tirzepatide | Injection | Chemical Drugs(1) | Import Drug Application | 2019-04-10 | Eli Lilly and Company | Eli Lilly & Company | In Review | 2019-04-09 | view |
| JXHS0800068 | 盐酸度洛西汀肠溶胶囊 | duloxetine hydrochloride | Capsule | Chemical Drugs | Import Drug Application | 2008-12-02 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2009-10-21 | view |
| JXHL1800091 | Baricitinib (LY3009104)片 | baricitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2018-08-13 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2018-09-30 | view |
| JXHL2100062 | Tirzepatide注射液 | tirzepatide | Injection | Chemical Drugs(1) | Import Drug Application | 2021-02-25 | Eli Lilly and Company | Eli Lilly & Company | In Review | 2021-02-24 | view |
| JXHL1400265 | LY2157299 | galunisertib | Other | Chemical Drugs | Import Drug Application | 2014-07-31 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2015-10-27 | view |
| JXSL2000118 | Ramucirumab | ramucirumab | Injection | Biological Products | Import Drug Application | 2020-07-04 | Eli Lilly and Company | Eli Lilly & Company | In Review | 2020-07-03 | view |
| JXHL1100127 | 盐酸度洛西汀肠溶胶囊 | duloxetine hydrochloride | Capsule | Chemical Drugs | Import Drug Application | 2011-04-29 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2013-01-25 | view |
| JXHL1900301 | Tirzepatide注射液 | tirzepatide | Injection | Chemical Drugs(1) | Import Drug Application | 2019-11-09 | Eli Lilly and Company | Eli Lilly & Company | In Review | 2019-11-08 | view |
| JYHB0900828 | 奥氮平双羟萘酸盐长效注射剂 | olanzapine pamoate | Injection | Chemical Drugs | Supplementary Application | 2009-09-16 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2010-06-24 | view |
| JXHL1800183 | Lasmiditan(LY573144) 半琥珀酸盐片 | lasmiditan succinate | Tablet | Chemical Drugs(1) | Import Drug Application | 2018-12-25 | Eli Lilly and Company | Eli Lilly & Company | In Review | 2018-12-24 | view |
| J0300543 | 盐酸度洛西汀胶囊 | duloxetine hydrochloride | Capsule | Chemical Drugs(1.1) | Import Drug Application | 2003-12-28 | Eli Lilly and Company | Eli Lilly & Company | Approval Completed-Pending Certificated | 2004-04-13 | view |
| JXSL1600001 | 重组赖脯胰岛素 | | | Biological Products | Import Drug Application | 2016-01-31 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2018-03-09 | view |
| JXHB2000006 | Baricitinib (LY3009104)片 | baricitinib | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2020-08-06 | Eli Lilly and Company | Eli Lilly & Company | In Review | 2020-08-05 | view |
| JXHL1200368 | 盐酸氟西汀胶囊 | fluoxetine hydrochloride | Capsule | Chemical Drugs | Import Drug Application | 2012-12-07 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2015-12-03 | view |
